Chargement en cours...

Evodiamine Synergizes with Doxorubicin in the Treatment of Chemoresistant Human Breast Cancer without Inhibiting P-Glycoprotein

Drug resistance is one of the main hurdles for the successful treatment of breast cancer. The synchronous targeting of apoptosis resistance and survival signal transduction pathways may be a promising approach to overcome drug resistance. In this study, we determined that evodiamine (EVO), a major c...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Wang, Shengpeng, Wang, Lu, Shi, Zhi, Zhong, Zhangfeng, Chen, Meiwan, Wang, Yitao
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4022620/
https://ncbi.nlm.nih.gov/pubmed/24830744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0097512
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!